PHILADELPHIA, November 5, 2018-- Group K Diagnostics, a healthcare innovator revolutionizing patient care with accurate, fast and affordable diagnoses, announced today it has secured $2 million in Series A funding. The announcement comes on the heels of the company's $425,000 Angel round, disclosed in September of this year. The funding achieved to date has been used to expand GKD's laboratory infrastructure, with new hires made for lab technicians.